Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Paragon 28 Community
NYSE:FNA Community
1
Narratives
written by author
0
Comments
on narratives written by author
0
Fair Values set
on narratives written by author
Create a narrative
Paragon 28
Popular
Undervalued
Overvalued
Community Investing Ideas
Paragon 28
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Thirteen New Products Will Expand Global Market Presence
Key Takeaways Paragon 28's innovative products and international market penetration are expected to drive sustainable revenue growth and diversification. Operational excellence and cost optimization efforts are set to achieve EBITDA and cash flow positivity, enhancing profitability and financial strength.
View narrative
US$14.50
FV
9.7% undervalued
intrinsic discount
13.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
27 days ago
author updated this narrative
Your Valuation for
FNA
FNA
Paragon 28
Your Fair Value
US$
Current Price
US$13.09
15.2% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-66m
469m
2015
2018
2021
2024
2025
2027
2030
Revenue US$469.1m
Earnings US$67.9m
Advanced
Set Fair Value